The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
AstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the US for the add-on maintenance treatment of adult and ...
Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...
The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.
The Long-Acting Beta-Agonists (LABA) market is entering a decade of transformative growth, projected to reach USD 18.0 billion by 2035 from USD 8.8 billion in 2025. With a compound annual growth rate ...
Everyday Health on MSN
Obesity and Diabetes Cause Chronic Inflammation: Here’s What to Do About It
Chronic inflammation can come from obesity and type 2 diabetes, and the two conditions also can cause inflammation. Learn how lifestyle changes can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback